HOME >> BIOLOGY >> NEWS
New Northwestern center targets brain disorders

combining molecular biology and gene discovery with the pragmatism of engineering in order to solve this problem and others."

The second potential therapy is based on the discovery by Moskal and colleagues of a family of molecules called glyxins that appear to enhance learning and memory. The Food and Drug Administration recently approved the glyxins for human phase I trials.

"The glyxins also may have an impact on attention deficit hyperactivity disorder, memory loss associated with the early stages of Alzheimer's disease as well as normal aging, damage due to stroke, and neuropathic pain," said Moskal. He has collaborated for years with John Disterhoft, professor of physiology at Feinberg, in evaluating the compounds.

Recently, another long-time collaborator, Jaak Panksepp, an emeritus professor in the psychology department at Bowling Green State University, joined the Falk Center as head of its affective neuroscience research program.

The Falk Center puts state-of-the-art gene chip technology -- the same used to discover the glyxins and the brain tumor therapy -- into the hands of Northwestern faculty and students. This technology, used to identify gene targets for new therapeutics, is more often found in the private sector than in universities.

"Very few universities in the country have direct access to gene chip technology of this caliber," said Roger Kroes, chief of molecular neuro-oncology at Falk and assistant research professor of biomedical engineering. "In the Chicago area, only a handful of programs in academia and the private sector combined have facilities equivalent to the Falk Center's."

Moskal and his staff build their own microarrays from scratch and are continually evolving the technology. Now they can train faculty, undergraduate and graduate students, and visiting scholars to build customized gene chips for their own discoveries. Moskal and his staff already have taught a class in advanced mo
'"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
10-Feb-2003


Page: 1 2 3

Related biology news :

1. Northwesterns Cancer Genetics Program pinpoints gene that increases cancer risk by 26 percent
2. Northwestern receives $5.65 million for reproductive research
3. Northwestern launches major gene banking project
4. A little larceny comes naturally to Northwestern crows
5. Northwestern receives $17 million for functional genomics research
6. Northwestern program aims at revealing genetic causes of spina bifida
7. Northwestern researchers map gene mutation that makes mice deaf and causes them to dance
8. Northwestern scientists shed new light on neurodegenerative diseases
9. Northwestern researchers clone gene responsible for inner ear motor
10. Northwestern team identifies first enzyme in mammalian circadian clock
11. Northwestern Hosts Public Forum On Future Of Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Northwestern center targets brain disorders

(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
(Date:6/17/2015)... GERMANTOWN, Maryland , June 17, 2015 ...   Produktlinie mit DNA-Tests verbessert den Analyseprozess und ... QGEN ; Frankfurt Prime Standard: QIA) hat heute in ... Produktlinie Investigator ® für ... Die neuen Kits zur Erstellung genetischer Fingerabdrücke bieten eine ...
(Date:6/16/2015)... 16, 2015  With the increasing number and severity ... top concern. The recent compromise of Federal employee ... strong authentication within government agencies. HYPR Corp. ... password (OTP) authenticator, has been submitted for testing and ... 3 validation for tamper proofing. The ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
(Date:6/29/2015)... , June 29, 2015  AACC, a global ... health through laboratory medicine, is pleased to announce ... Clinical Chemistry , has increased to 7.9 in ... increase places Clinical Chemistry in the ... the significant influence of the research it publishes ...
(Date:6/29/2015)... -- Neuralstem, Inc. (NYSE MKT: CUR), a biopharmaceutical company using ... cell therapy treatments for central nervous system diseases, announced ... the NASDAQ Capital Market under the symbol "CUR." The ... NYSE MKT until the market close on July 10, ... to commence on July 13, 2015. ...
(Date:6/29/2015)... ... June 29, 2015 , ... The StampedeCon ... and for the fourth year in a row, will bring top technology professionals to ... place at the intersection of data and technology. The event is proudly sponsored by ...
(Date:6/29/2015)... 2015   For the seventh year running, Across Health ... overall digital maturity called the Multichannel Maturometer . ... not maturing fast enough. While it,s true that technology ... overall and customers are increasingly "digital natives", pharma still ... engagement.  ...
Breaking Biology Technology:AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 2AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 3Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 2Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 3StampedeCon Announces 2015 Agenda 2StampedeCon Announces 2015 Agenda 3Results from Digital Maturity Study Show Pharma Lagging 2Results from Digital Maturity Study Show Pharma Lagging 3Results from Digital Maturity Study Show Pharma Lagging 4
Cached News: